Chu de Bordeaux
Bordeaux, France
NCT Number: NCT06706934
Each form of intellectual disability under study is a rare disease in its own right, and it is therefore difficult to study the variability of its expression. It therefore appears necessary to study large series of patients with intellectual disabilities. The objective is to identify variants in phenotype-modifying genes in patients with intellectual disability.
Trial opening soon.
Get NotifiedAll sexes
Observational
Bordeaux, France
Thanks to the contribution of NGS analyses (exome and genome analysis), the rate of etiological diagnosis in intellectual disability is currently approaching 42% in some meta-analyses. At Bordeaux University Hospital, since 2017, 700 patients have been sequenced for intellectual disability, with a diagnostic rate of 33%.
In genetics, epistasis refers to the interaction between two or more genes. As part of its previous work, BIONOMEEX has developed an algorithm called GWAS-2D (genome wide association study 2 dimension) which makes it possible to observe, from a large number of samples and for a given phenotype, the relationships existing between two loci on the genome.
The GWAS-2DI project involves the reanalysis of exome sequencing data from patients with intellectual disabilities at Bordeaux University Hospital, using a GWAS-2D algorithm developed by BIONOMEEX to search for phenotype-modifying genes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Inclusion visit
Identifying variants in phenotype-modifying genes in patients with intellectual disability.
Time frame: Inclusion visit
Correlation phenotypic traits with additional diagnostic variants
Contact information is provided by the study sponsor or research team.
University Hospital, Bordeaux
Other
Search for Phenotype-modifying Genes in Patients With Intellectual Disabilities GWAS-2DI.
Acronym: GWAS-2DI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07531940
Abnormalities, Multiple, Chromosome Disorders
Cleveland, Ohio, United States
View Trial DetailsNCT07504874
Intellectual Disability, Mental Disorders
View Trial DetailsNCT07400913
Albinism, Amino Acid Metabolism, Inborn Errors
Bordeaux, France
View Trial DetailsNCT07245160
Anxiety Disorders, Autism Spectrum Disorder
London, Ontario, Canada
View Trial Details